TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
SCYX

Scynexis Inc

Healthcare · Drug Manufacturers - Specialty & Generic

4.90$ +6.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Scynexis Inc (SCYX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 59 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SCYX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
40 49 60 46 53 57 103 120 88 128 91 59
40 48 59 45 51 52 98 109 79 102 72 40
32 47 36 11 11 42 93 104 46 34 16 21
32 47 59 44 44 48 93 104 74 74 59 21
0.2 0.9 0.2 0.3 6.7 – 2.9 0.9 2.1 22 10 –
7.2 0.5 0.5 0.7 0.5 – 1.9 0.5 0.9 0.0 – –
4.8 0.0 0.0 0.0 0.5 0.4 3.3 0.1 – – – –
0.0 0.0 0.0 0.0 – – – – – – – –
0.0 0.0 0.0 0.0 – – – 1.1 0.4 – – –
6.2 7.3 25 24 22 44 80 79 85 55 36 9.7
5.3 6.7 3.7 10 5.9 11 26 14 18 16 24 5.7
2.2 – 14 4.3 – 0.0 0.1 0.1 0.3 0.3 14 0.5
0.4 0.6 2.2 3.8 3.7 7.2 4.6 7.8 5.9 7.1 4.6 2.2
0.0 0.0 14 10 15 12 17 29 45 12 – –
33 42 35 21 31 13 23 41 3.2 73 55 49
-118 -150 -180 -205 -218 -271 -327 -359 -422 -355 -377 -385
0.1 0.2 1.9 0.3 0.5 0.7 1.3 3.3 5.3 6.0 6.1 6.2

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?